Commonwealth Equity Services’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$269K	Sell	3,495 -140	-4%	-$10.9K	﹤0.01%	3734
2025 Q4	$287K	Sell	3,635 -3,188	-47%	-$276K	﹤0.01%	3685
2025 Q3	$625K	Sell	6,823 -1,229	-15%	-$100K	﹤0.01%	2992
2025 Q2	$525K	Sell	8,052 -5,497	-41%	-$358K	﹤0.01%	3096
2025 Q1	$907K	Buy	13,549 +2,037	+18%	+$122K	﹤0.01%	2533
2024 Q4	$636K	Sell	11,512 -276	-2%	-$15.8K	﹤0.01%	2770
2024 Q3	$703K	Sell	11,788 -326	-3%	-$19.9K	﹤0.01%	2612
2024 Q2	$771K	Sell	12,114 -750	-6%	-$48.7K	﹤0.01%	2481
2024 Q1	$889K	Sell	12,864 -40	-0.3%	-$2.42K	﹤0.01%	2341
2023 Q4	$712K	Sell	12,904 -249	-2%	-$13.7K	﹤0.01%	2417
2023 Q3	$764K	Hold	13,153	–	–	﹤0.01%	2261
2023 Q2	$708K	Sell	13,153 -475	-3%	-$21.1K	﹤0.01%	2353
2023 Q1	$541	Hold	13,628	–	–	﹤0.01%	2487
2022 Q4	$548K	Buy	13,628 +500	+4%	+$18.8K	﹤0.01%	2394
2022 Q3	$421K	Buy	13,128 +785	+6%	+$26.9K	﹤0.01%	2557
2022 Q2	$366K	Buy	12,343 +100	+0.8%	+$2.88K	﹤0.01%	2652
2022 Q1	$344K	Buy	12,243 +765	+7%	+$28.5K	﹤0.01%	2852
2021 Q4	$528K	Buy	+11,478	New	+$493K	﹤0.01%	2476
2017 Q1	–	Sell	-4,668	Closed	-$283K	–	2416
2016 Q4	$283K	Sell	4,668 -180	-4%	-$11K	﹤0.01%	1807
2016 Q3	$322K	Buy	4,848 +279	+6%	+$17.5K	﹤0.01%	1657
2016 Q2	$255K	Buy	+4,569	New	+$222K	﹤0.01%	1776